Acella Pharmaceuticals, LLC

GA · United States · Reporting entity ID 100000196863

Total reported 2019–2025

$6.64M

#618 of 2,960 reporting companies — 0% of all reported industry payments

$439K in general payments across 7,357 records, plus $6.20M in research funding across 542 records.

How it breaks down

General payments $438,878

Research funding $6,199,944

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.